Role of pharmacodynamics in designing dosage regimens for beta-lactams.
Kotapati
Srividya
S
Center for Anti-Infective Research and Development, Hartford Hospital, USA.
Kuti
Joseph L
JL
Nightingale
Charles H
CH
Nicolau
David P
DP
D000900:Anti-Bacterial Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D000077723:Cefepime; D002511:Cephalosporins / Q000008:administration & dosage / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077731:Meropenem; D010397:Penicillanic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D010878:Piperacillin / Q000008:administration & dosage / Q000493:pharmacokinetics; D000078142:Tazobactam; D013845:Thienamycins / Q000008:administration & dosage / Q000493:pharmacokinetics
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D000077723:Cefepime; D010397:Penicillanic Acid; D000077731:Meropenem; D000078142:Tazobactam; D010878:Piperacillin